MedTrace Logo

Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects

NCT04074369 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2019-08-30

No results posted yet for this study

Summary

This observational Mycobacterium tuberculosis (MTB) diagnostics evaluation study is a prospective study of pulmonary TB suspects who are undergoing sputum or bronchoalveolar lavage fluid (BALF) evaluation for pulmonary TB. The sensitivity and specificity of the CRISPR-based assay will be compared to clinical diagnosis, conventional culture methods and Xpert MTB/RIF assay on same batch specimens.

Conditions

  • Tuberculosis, Pulmonary

Interventions

DIAGNOSTIC_TEST

CRISPR-based Test

CRISPR-based Test performed on sputum or BALF in TB suspects.

Sponsors & Collaborators

  • Wenzhou Central Hospital

    collaborator OTHER

  • Red Cross Hospital, Hangzhou, China

    collaborator OTHER

  • Huashan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2019-10-30
Completion
2019-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04074369 on ClinicalTrials.gov